[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]

June 2017, Vol 2, No. 6, Pages 585-705

In This Issue of JAMA Cardiology

Highlights

Abstract Full Text
free access
JAMA Cardiol. 2017;2(6):585. doi:10.1001/jamacardio.2016.3649
Viewpoint

Collaborative Care in an Evolving Health Care Delivery LandscapeCardiology Fellows in Training and Advanced Practice Professionals

Abstract Full Text
JAMA Cardiol. 2017;2(6):587-588. doi:10.1001/jamacardio.2017.0492

This Viewpoint discusses the landscape and future directions of interactions between fellows in training and advanced practice professionals in academic cardiology programs.

Balancing the Training of Future Cardiologists With the Provision of Team-Based Care

Abstract Full Text
JAMA Cardiol. 2017;2(6):589-590. doi:10.1001/jamacardio.2017.0555

This Viewpoint discusses ways to balance the roles of advanced practice clinicians with the training of cardiology fellows.

Shared Goals and Clear Roles for Cardiovascular Team-Based Care

Abstract Full Text
JAMA Cardiol. 2017;2(6):591-592. doi:10.1001/jamacardio.2017.0556

This Viewpoint discusses the role of advanced practice professionals in cardiovascular team-based care and highlights the importance of shared goals and outlining clear roles.

Editorial

Early Identification of Pregnant Women at Risk for PreeclampsiaUSPSTF Recommendations on Screening for Preeclampsia

Abstract Full Text
JAMA Cardiol. 2017;2(6):593-595. doi:10.1001/jamacardio.2017.1276

This editorial evaluates the most recent USPSTF recommendations on screening pregnant women for preeclampsia and especially the importance of blood pressure measurement.

Factors Affecting the Cost of Airplanes and Use of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors

Abstract Full Text
JAMA Cardiol. 2017;2(6):596-597. doi:10.1001/jamacardio.2017.0760
Original Investigation

Long-term Low-Density Lipoprotein Cholesterol–Lowering Efficacy, Persistence, and Safety of Evolocumab in Treatment of HypercholesterolemiaResults Up to 4 Years From the Open-Label OSLER-1 Extension Study

Abstract Full Text
open access
JAMA Cardiol. 2017;2(6):598-607. doi:10.1001/jamacardio.2017.0747

This observational extension of the OSLER-1 randomized clinical trial determines whether low-density lipoprotein cholesterol level reductions with evolocumab persist across different patient populations.

Effect of Monthly High-Dose Vitamin D Supplementation on Cardiovascular Disease in the Vitamin D Assessment Study A Randomized Clinical Trial

Abstract Full Text
JAMA Cardiol. 2017;2(6):608-616. doi:10.1001/jamacardio.2017.0175

This randomized clinical trial examines whether monthly high-dose vitamin D supplementation prevents cardiovascular disease in the general population.

Effect of Baseline Nutritional Status on Long-term Multivitamin Use and Cardiovascular Disease RiskA Secondary Analysis of the Physicians’ Health Study II Randomized Clinical Trial

Abstract Full Text
JAMA Cardiol. 2017;2(6):617-625. doi:10.1001/jamacardio.2017.0176

This secondary analysis of the Physicians’ Health Study II randomized clinical trial investigates effect modification by various baseline dietary factors on cardiovascular disease risk.

Hospital Admissions for Myocardial Infarction and Stroke Before and After the Trans-Fatty Acid Restrictions in New York

Abstract Full Text
JAMA Cardiol. 2017;2(6):627-634. doi:10.1001/jamacardio.2017.0491

This study determines whether trans-fatty acid restrictions in New York State counties were associated with fewer hospital admissions for myocardial infarction and stroke compared with counties without restrictions.

Coronary Artery Calcification and Risk of Cardiovascular Disease and Death Among Patients With Chronic Kidney Disease

Abstract Full Text
JAMA Cardiol. 2017;2(6):635-643. doi:10.1001/jamacardio.2017.0363

This cohort study assesses the prospective association of coronary artery calcification with risk of cardiovascular disease and all-cause mortality among dialysis-naive adult patients with chronic kidney disease from 7 US clinical centers.

Subclinical Atherosclerosis, Statin Eligibility, and Outcomes in African American IndividualsThe Jackson Heart Study

Abstract Full Text
JAMA Cardiol. 2017;2(6):644-652. doi:10.1001/jamacardio.2017.0944

This community-based study compares the relative accuracy of US Preventive Services Task Force and American College of Cardiology/American Heart Association recommendations in identifying African American individuals with subclinical and clinical atherosclerotic cardiovascular disease.

Heterogeneity in Blood Pressure Transitions Over the Life CourseAge-Specific Emergence of Racial/Ethnic and Sex Disparities in the United States

Abstract Full Text
JAMA Cardiol. 2017;2(6):653-661. doi:10.1001/jamacardio.2017.0652

This cross-sectional study estimates age-, racial/ethnic-, and sex-specific annual net transition probabilities between categories of blood pressure using Markov modeling of cross-sectional data from the National Health and Nutrition Examination Survey.

Maternal and Fetal Outcomes of Admission for Delivery in Women With Congenital Heart Disease

Abstract Full Text
JAMA Cardiol. 2017;2(6):664-671. doi:10.1001/jamacardio.2017.0283

This study of all delivery admissions in the California State Inpatient Database compares maternal and fetal risks and outcomes between women with and without congenital heart disease.

Brief Report

Effect of Short Procedural Duration With Bivalirudin on Increased Risk of Acute Stent Thrombosis in Patients With STEMIA Secondary Analysis of the HORIZONS-AMI Randomized Clinical Trial

Abstract Full Text
JAMA Cardiol. 2017;2(6):673-677. doi:10.1001/jamacardio.2016.5669

This secondary analysis of a randomized clinical trial assesses whether a link exists between the length of procedure time and acute stent thrombosis in patients treated with bivalirudin vs heparin plus glycoprotein IIb/IIIa inhibitor.

Value of Cardiovascular Magnetic Resonance Imaging in Noninvasive Risk Stratification in Tetralogy of Fallot

Abstract Full Text
JAMA Cardiol. 2017;2(6):678-683. doi:10.1001/jamacardio.2016.5818

This study uses cardiovascular magnetic resonance imaging in noninvasive risk stratification to predict major adverse clinical outcomes in patients with tetralogy of Fallot.

Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic CardiomyopathyA Meta-analysis

Abstract Full Text
JAMA Cardiol. 2017;2(6):685-688. doi:10.1001/jamacardio.2017.0630

This meta-analysis investigates the association of primary prevention implantable cardioverter defibrillators with all-cause mortality in patients with nonischemic cardiomyopathy.

Invited Commentary

Inconclusive Supplement Benefit, but Undisputed Advantages of Healthy Foods

Abstract Full Text
JAMA Cardiol. 2017;2(6):625-626. doi:10.1001/jamacardio.2017.0217

Hypertension DisparitiesThe Hidden Vulnerability of Youth

Abstract Full Text
JAMA Cardiol. 2017;2(6):661-663. doi:10.1001/jamacardio.2017.0666

Pregnancy in Adult Congenital Heart DiseaseSpecial Delivery

Abstract Full Text
JAMA Cardiol. 2017;2(6):671-672. doi:10.1001/jamacardio.2017.0365

Myocardial Dysfunction in Tetralogy of Fallot and Its Association With Outcome

Abstract Full Text
JAMA Cardiol. 2017;2(6):683-684. doi:10.1001/jamacardio.2016.6020
Review

Sudden Cardiac Arrest Risk AssessmentPopulation Science and the Individual Risk Mandate

Abstract Full Text
has active quiz
JAMA Cardiol. 2017;2(6):689-694. doi:10.1001/jamacardio.2017.0266

This review synthesizes data on risk assessment for sudden cardiac death and sudden cardiac arrest from population studies that included large longitudinal and cross-sectional databases, observational cohort studies, and randomized clinical trials.

JAMA Cardiology Clinical Challenge

A 67-Year-Old Man With Irregular Pulse

Abstract Full Text
has multimedia
JAMA Cardiol. 2017;2(6):695-696. doi:10.1001/jamacardio.2017.0508

A 67-year-old white man with a history of hypertension presents to your hospital after noting irregular heartbeats on his home blood pressure monitor. He has no palpitations; the electrocardiogram shows several premature ventricular contractions. What would you do next?

JAMA Cardiology Diagnostic Test Interpretation

Low-Density Lipoprotein Measurement DiscordanceWhen 2 Wrongs Lead to the Right Answer—Elevated Lipoprotein (a)

Abstract Full Text
JAMA Cardiol. 2017;2(6):697-698. doi:10.1001/jamacardio.2017.0256

A 47-year old man presented with a marked difference between his direct and calculated low-density lipoprotein cholesterol levels and elevated levels of lipoprotein (a). He had been treated with atorvastatin. How do you interpret these results?

Research Letter

Time-Related Microcirculatory Dysfunction in Patients With Takotsubo Cardiomyopathy

Abstract Full Text
JAMA Cardiol. 2017;2(6):699-700. doi:10.1001/jamacardio.2016.5993

This study assesses whether there is a time-dependent trend in microvascular damage in patients presenting with takotsubo cardiomyopathy by invasively measuring the index of microvascular resistance.

Recovery in Patients With Dilated Cardiomyopathy With Loss-of-Function Mutations in the Titin Gene

Abstract Full Text
JAMA Cardiol. 2017;2(6):700-702. doi:10.1001/jamacardio.2017.0763

This study compares the prevalence of titin gene mutations in patients with dilated cardiomyopathy receiving standard pharmacological therapy with and without recovery of systolic function.

Comment & Response

Association of Depression and Cardiovascular DiseaseWhich Comes First?

Abstract Full Text
JAMA Cardiol. 2017;2(6):702. doi:10.1001/jamacardio.2016.5984

Association of Depression and Cardiovascular Disease

Abstract Full Text
JAMA Cardiol. 2017;2(6):702-703. doi:10.1001/jamacardio.2016.5987

Association of Depression and Cardiovascular Disease—Reply

Abstract Full Text
JAMA Cardiol. 2017;2(6):703. doi:10.1001/jamacardio.2016.5999

Prognosis Using Planar Imaging in Cardiac Amyloidosis

Abstract Full Text
JAMA Cardiol. 2017;2(6):704. doi:10.1001/jamacardio.2016.5885

Prognosis Using Planar Imaging in Cardiac Amyloidosis—Reply

Abstract Full Text
JAMA Cardiol. 2017;2(6):704-705. doi:10.1001/jamacardio.2016.5888
Editor's Note

Integrating Research With Clinical PracticeKeeping It Simple

Abstract Full Text
free access
JAMA Cardiol. 2017;2(6):616. doi:10.1001/jamacardio.2017.0216
Correction

Correction of Axis Labels in 3 Figures

Abstract Full Text
free access
JAMA Cardiol. 2017;2(6):705. doi:10.1001/jamacardio.2017.0972
JAMA Cardiology Masthead

JAMA Cardiology

Abstract Full Text
free access
JAMA Cardiol. 2017;2(6):586. doi:10.1001/jamacardio.2016.3650
×